STK4 and thyroid gland carcinoma: This was further supported by results obtained by Peng et al. in thyroid cancer, where STK4 silencing resulted in a reduction in key proteins involved in cell cycle arrest via Hippo signaling (MST1, LAST1, and LAST2), resulting in the promotion of carcinogenic phenotypes.